Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients
Clinical trial NCT01352208 · TERMINATED
Trial details
- NCT number
- NCT01352208
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.